Ladenburg Thalmann Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $568K | Buy |
15,728
+6,152
| +64% | +$222K | ﹤0.01% | 1708 |
|
2019
Q3 | $261K | Buy |
9,576
+1,912
| +25% | +$52.1K | ﹤0.01% | 2265 |
|
2019
Q2 | $185K | Sell |
7,664
-2,212
| -22% | -$53.4K | ﹤0.01% | 2534 |
|
2019
Q1 | $261K | Sell |
9,876
-664
| -6% | -$17.5K | ﹤0.01% | 2196 |
|
2018
Q4 | $208K | Buy |
10,540
+1,327
| +14% | +$26.2K | ﹤0.01% | 2221 |
|
2018
Q3 | $180K | Buy |
9,213
+122
| +1% | +$2.38K | ﹤0.01% | 2397 |
|
2018
Q2 | $128K | Hold |
9,091
| – | – | ﹤0.01% | 2594 |
|
2018
Q1 | $128K | Buy |
9,091
+3,877
| +74% | +$54.6K | ﹤0.01% | 2594 |
|
2017
Q4 | $76K | Sell |
5,214
-908
| -15% | -$13.2K | ﹤0.01% | 2930 |
|
2017
Q3 | $78K | Buy |
6,122
+788
| +15% | +$10K | ﹤0.01% | 2769 |
|
2017
Q2 | $63K | Sell |
5,334
-1,211
| -19% | -$14.3K | ﹤0.01% | 2872 |
|
2017
Q1 | $96K | Sell |
6,545
-1,998
| -23% | -$29.3K | ﹤0.01% | 2437 |
|
2016
Q4 | $139K | Sell |
8,543
-10,038
| -54% | -$163K | ﹤0.01% | 2076 |
|
2016
Q3 | $336K | Sell |
18,581
-5,835
| -24% | -$106K | 0.01% | 1416 |
|
2016
Q2 | $402K | Sell |
24,416
-1,704
| -7% | -$28.1K | 0.01% | 1263 |
|
2016
Q1 | $433K | Sell |
26,120
-1,768
| -6% | -$29.3K | 0.01% | 1138 |
|
2015
Q4 | $603K | Buy |
27,888
+16,099
| +137% | +$348K | 0.01% | 924 |
|
2015
Q3 | $237K | Buy |
11,789
+5,582
| +90% | +$112K | ﹤0.01% | 1371 |
|
2015
Q2 | $215K | Buy |
6,207
+5,834
| +1,564% | +$202K | ﹤0.01% | 1567 |
|
2015
Q1 | $8K | Buy |
+373
| New | +$8K | ﹤0.01% | 3781 |
|
2014
Q4 | – | Sell |
-205
| Closed | -$3K | – | 4497 |
|
2014
Q3 | $3K | Hold |
205
| – | – | ﹤0.01% | 3612 |
|
2014
Q2 | $3K | Buy |
+205
| New | +$3K | ﹤0.01% | 3574 |
|